© 1990 British Society for Rheumatology
research-article |
THE EFECT OF NABUMETONE AND ITS PRINCIPAL ACTIVE METABOLITE ON IN VITRO HUMAN GASTRIC MUCOSAL PROSTANOID SYNTHESIS AND PLATELET FUNCTION
Metabolic Unit, Department of Chemical Pathology and Human Metabolism Pond Street, London NW3 2QG
*Department of Surgery, Royal Free Hospital and School of Medicine Pond Street, London NW3 2QG
Correspondence to:
Correspondence to Dr J. Jeremy.
Nabumetone is a novel non-steroidal anti-inflammatory drug (NS AID) which although a weak cyclooxygenase inhibitor is converted by the liver to metabolites which are more potent inhibitors of cyclooxygenae. Nabumetone may thus avoid the occurrence of gastric erosion while maintaining its efficacy as an anti-inflammatory drug. We compared the effects of nabumetone and 6-methoxy-2-naphthylacetic acid (6MNA; the principal metabolite of nabumetone) with naproxen and indomethacin on in vitro synthesis of the gastroprotective prostaglandins I2 and E2 by human gastric mucosa. To study the effects of 6MN A on peripheral target tissues the effects of the above NSAIDs on uman platelet aggregation and thromboxane A2 synthesis were also studied. Prostanoid synthesis by the human gastric mucosa was inhibited by indomethacin, naproxen and 6MNA (in this order of potency) whereas nabumetone was completely without effect. Platelet aggregation and thromboxane A2 synthesis were similarly inhibited by the NSAIDS (viz. indomethacin > naproxen > 6MNA > nabumetone).These results support the view that nabumetone does not inhibit gastroprotective prostanoid synthesis,whereas its active metabolite 6MNA is an effective inhibitor of prostanoid synthesis in target tissues.
KEY WORDS: Prodrug, Gastropath, Prostacyclin, Prostaglandin E2, Thromboxane A2
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Wan, N. Shukla, G. D. Angelini, A. P.C. Yim, J. L. Johnson, and J. Y. Jeremy Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: A comparison with aspirin and morpholinosydnonimine (SIN-1). J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Schimizzi, A. A. Jamali, K. D. Herbst, and R. A. Pedowitz Acute Compartment Syndrome Due to Ruptured Baker Cyst After Nonsurgical Management of an Anterior Cruciate Ligament Tear: A Case Report Am. J. Sports Med., April 1, 2006; 34(4): 657 - 660. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. J. Knijff-Dutmer, E. M. Kalsbeek-Batenburg, J. Koerts, and M. A. F. J. van de Laar Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis Rheumatology, April 1, 2002; 41(4): 458 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H.K. Huang Rheumatology: 7. Basics of therapy Can. Med. Assoc. J., August 1, 2000; 163(4): 417 - 423. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A J Knijff-Dutmer, A. Martens, and M. A F J v. Laar Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis Ann Rheum Dis, April 1, 1999; 58(4): 257 - 259. [Abstract] [Full Text]
|
|